Dianthus Therapeutics | MGTA - Le Bénéfice D'Exploitation





Le Bénéfice D'Exploitation Changement Date
Akebia Therapeutics USD 13.51M 27.82M 2025-03
Alaunos Therapeutics USD -1.19M 432K 2025-09
Avita Medical AUD -10.41M 742K 2025-12
Celltrion KRW 301.04B 58.57B 2025-09
Cspc Pharmaceutical CNY 1.22B 60.54M 2025-09
Deva Holding AS TRY 964.87M 240.32M 2023-09
Dianthus Therapeutics USD -40.29M 5.36M 2025-09
Divis Laboratories Ltd INR 7.72B 30M 2025-12
IQVIA Holdings USD 2.68B 2.1B 2025-12
Kangmei Pharma CNY -26.7M 43.13M 2025-09
Knight Therapeutics CAD 2.94M 2.4M 2025-09
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Malin Corporation EUR -1.1M 400K 2024-12
Medical Developments International AUD -36K 444K 2025-12
Moderna USD -857M 597M 2025-12
Neuren Pharmaceuticals AUD 17.01M 11.56M 2025-12
Organigram Holdings CAD -28.05M 7.76M 2025-09
Organon & Co USD 388M 62M 2025-09
Ovoca Bio EUR -5.65M 3.45M 2022-06
Pharma Mar EUR 43.61M 47.57M 2025-12
Qiagen NV USD 121.88M 15.41M 2025-12
Revvity USD 145.83M 47.49M 2025-12
Sartorius EUR 150.1M 11.7M 2025-09
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Tectonic Therapeutic USD -21.89M 440K 2025-09
Tilray USD -20.01M 9.34M 2025-09
Viatris USD -157.5M 392M 2025-12
Xeris Pharmaceuticals USD 6.73M 2.25M 2025-09
Zz Pientze Pharmaceu CNY 501.33M 52.54M 2025-09